Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000028

CEO bought 179,000 shares at an average $0.01 ($1,974)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

30 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-01 Purchase : show line 1 in the form +2,000 $0.01 $24 21,160,123 D
2019-05-01 Purchase : show line 2 in the form +2,000 $0.01 $23 21,162,123 D
2019-05-01 Purchase : show line 3 in the form +5,000 $0.01 $57 21,167,123 D
2019-05-01 Purchase : show line 4 in the form +5,000 $0.01 $59 21,172,123 D
2019-05-01 Purchase : show line 5 in the form +2,000 $0.01 $24 21,174,123 D
2019-05-01 Purchase : show line 6 in the form +2,000 $0.01 $24 21,176,123 D
2019-05-01 Purchase : show line 7 in the form +2,000 $0.01 $24 21,178,123 D
2019-05-01 Purchase : show line 8 in the form +2,000 $0.01 $24 21,180,123 D
Open-market purchases · 179,000 sh · avg $0.01 · $1,974
Loading xslF345X03/primary_doc.xml…